About: Randomized, Double-Blind, Placebo Controlled Study of Vilazodone's Efficacy, Safety, and Biomarkers of Response in Major Depressive Disorder (MDD)

Facets (new session)
Description
Metadata
Settings
- owl:sameAs
- Inference Rule:

About: Randomized, Double-Blind, Placebo Controlled Study of Vilazodone's Efficacy, Safety, and Biomarkers of Response in Major Depressive Disorder (MDD) Goto Sponge NotDistinct Permalink

An Entity of Type : wikibase:Item, within Data Space : wikidata.demo.openlinksw.com associated with source document(s)

clinical trial

Attributes	Values
rdf:type	Item
description	clinical trial (en) ensayu clínicu (ast) klinisch onderzoek (nl) клінічне випробування (uk)
rdfs:label	Randomized, Double-Blind, Placebo Controlled Study of Vilazodone's Efficacy, Safety, and Biomarkers of Response in Major Depressive Disorder (MDD) (en) Randomized, Double-Blind, Placebo Controlled Study of Vilazodone's Efficacy, Safety, and Biomarkers of Response in Major Depressive Disorder (MDD) (nl)
skos:prefLabel	Randomized, Double-Blind, Placebo Controlled Study of Vilazodone's Efficacy, Safety, and Biomarkers of Response in Major Depressive Disorder (MDD) (en) Randomized, Double-Blind, Placebo Controlled Study of Vilazodone's Efficacy, Safety, and Biomarkers of Response in Major Depressive Disorder (MDD) (nl)
name	Randomized, Double-Blind, Placebo Controlled Study of Vilazodone's Efficacy, Safety, and Biomarkers of Response in Major Depressive Disorder (MDD) (en) Randomized, Double-Blind, Placebo Controlled Study of Vilazodone's Efficacy, Safety, and Biomarkers of Response in Major Depressive Disorder (MDD) (nl)
title	wds:Q65378121-662EC596-6227-4F4B-9D33-3772FBCC70BC
title	A Randomized, Double-blind, Placebo Controlled Study Assessing the Efficacy and Safety of Vilazodone 40 mg qd and Evaluating Genetic Biomarkers Associated With Treatment Response in Patients With Major Depressive Disorder (MDD) (en)
end time	wds:Q65378121-CA24AE5E-7CA1-4B5B-AAC2-A5917B1A4F4D
end time	2009-02-01 00:00:00Z (xsd:dateTime)
instance of	wds:Q65378121-B2E33628-F109-48EA-9406-477CF95E2385
instance of	clinical trial
start time	wds:Q65378121-C4020295-E630-44FA-97BB-F174613E4EB5
start time	2008-03-01 00:00:00Z (xsd:dateTime)
country	wds:Q65378121-933129E0-A831-4A9A-8AAE-4B406FD1C94A
country	United States of America
research site	wds:Q65378121-57859086-73D3-4A50-BD1A-F67104436CFA wds:Q65378121-58EB1BC8-4866-4917-A642-3B505F3FBB93 wds:Q65378121-5AA5FE08-4409-446C-A6D2-55DF59AFC563
research site	Northwest Clinical Research Center Pharmacology Research Institute Summit Research Network
minimum age	wds:Q65378121-ACDB745C-DA02-451A-8421-D95326A6BE13
minimum age	18 (xsd:decimal)
number of participants	wds:Q65378121-09487D84-995C-4F38-9EC2-04D2045A3932
number of participants	481 (xsd:decimal)
maximum age	wds:Q65378121-87FF49B4-7272-4FF4-BFC6-51E32A121D4D
maximum age	70 (xsd:decimal)
study type	wds:Q65378121-7472685A-D426-4232-BB29-6FC666C69107
study type	interventional study
ClinicalTrials.gov ID	wds:Q65378121-54FF6C8E-62AD-428E-A4E0-D40A5910FB90
ClinicalTrials.gov ID	NCT00683592
clinical trial phase	wds:Q65378121-472DAD4E-71B2-48E2-B0DE-A18F5DFED255
clinical trial phase	phase III clinical trial
is about of	https://www.wikidata.org/wiki/Special:EntityData/Q65378121

Faceted Search & Find service v1.16.117 as of May 05 2024

Alternative Linked Data Documents: ODE Content Formats:

RDF

ODATA

Microdata

About

OpenLink Virtuoso version 07.20.3239 as of May 5 2024, on Linux (x86_64-centos_6-linux-gnu), Single-Server Edition (378 GB total memory, 190 GB memory in use)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2024 OpenLink Software